UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000055582
Receipt number R000063514
Scientific Title Treatment for tic disorders and Tourette's syndrome focusing on the striosome
Date of disclosure of the study information 2024/09/23
Last modified on 2024/09/22 13:50:23

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Dual dopaminergic therapy for tic disorder and Tourette's syndrome

Acronym

Investigating novel treatments for tic disorder and Tourette's syndrome

Scientific Title

Treatment for tic disorders and Tourette's syndrome focusing on the striosome

Scientific Title:Acronym

Researching effective treatments for tic disorders and Tourette's syndrome.

Region

Japan


Condition

Condition

Tic disorders and Tourette's syndrome

Classification by specialty

Neurology Psychiatry Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate whether administration of Wintamin and Dopacol is effective for tic disorder and Tourette's syndrome

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

YGTSS and YBOCS

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Prescribe Wintamin and Dopacol for patients with chronic tic disorders who visited our hospital and evaluate their symptoms.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

1 years-old <

Age-upper limit

120 years-old >=

Gender

Male and Female

Key inclusion criteria

Those who meet the diagnostic criteria for Juncos
1. Juncos JL, Freeman A: Pathophysiology and differential diagnosis of tics. In: Watts RL, Koller WC(eds), Movement Disorders. Neurologic Principles and Practice. McGraw-Hill, New York, 1997; 561-568.

Key exclusion criteria

Patients deemed ineligible by a physician

Target sample size

27


Research contact person

Name of lead principal investigator

1st name Shinnichi
Middle name
Last name Matsumoto

Organization

Osaka Neurological institute

Division name

Neurology

Zip code

5610836

Address

2-6-23 Shounai Takaramachi Toyonaka Osaka

TEL

0663330086

Email

dyt1mc@yahoo.co.jp


Public contact

Name of contact person

1st name Masahira
Middle name
Last name Kiyota

Organization

Osaka Neurological Institute

Division name

IRB

Zip code

5610836

Address

2-6-23 Shounai Takaramachi Toyonaka Osaka

TEL

0663330086

Homepage URL


Email

kiyota@oni.or.jp


Sponsor or person

Institute

Osaka Neurological Institute

Institute

Department

Personal name



Funding Source

Organization

Osaka Neurological Institute

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Osaka Neurological Institute / IRB

Address

2-6-23 Shounai Takaramachi Toyonaka Osaka

Tel

0663330086

Email

kiyota@oni.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 09 Month 23 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2024 Year 02 Month 21 Day

Date of IRB

2024 Year 02 Month 21 Day

Anticipated trial start date

2024 Year 03 Month 01 Day

Last follow-up date

2026 Year 03 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 09 Month 22 Day

Last modified on

2024 Year 09 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063514